ストックスクリーナーアプリを入手
4.00
8.11%
0.30
アフターアワーズ：
3.98
-0.02
-0.50%
Macrogenics Inc (MGNX) 最新ニュース
MacroGenics: Whipsaws On Clinical Data, But The Big Picture Is Still Important (MGNX) - Seeking Alpha
Citizens reiterates MacroGenics stock rating ahead of ESMO data - Investing.com
Citizens reiterates MacroGenics stock rating ahead of ESMO data By Investing.com - Investing.com Canada
MacroGenics Inc (MGNX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MacroGenics, Inc. Revenue Breakdown – NASDAQ:MGNX - TradingView
MGNX|MacroGenics Inc|Price:3.700|Chg%:-0.310 - TradingKey
MacroGenics Inc (MGNX) Cash Flow - TradingKey
MacroGenics, Inc. Revenue Breakdown – DUS:M55 - TradingView
TradingKey - TradingKey
MacroGenics slips on trial data for lead asset (MGNX:NASDAQ) - Seeking Alpha
MacroGenics Inc (MGNX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MacroGenics’ MGC026 meets Phase 1 trial milestone in SCCHN - Investing.com
MacroGenics (MGNX) Advances Phase 1 Study of MGC026 - GuruFocus
MacroGenics’ MGC026 meets trial threshold in head and neck cancer By Investing.com - Investing.com Nigeria
MacroGenics’ MGC026 meets trial threshold in head and neck cancer - Investing.com
MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026 - The Manila Times
Entera Bio Leads Our Top 3 Penny Stocks To Consider - Sahm
MGNX stock holds focus as MacroGenics plans and pipeline metrics matter - Ad-hoc-news.de
MacroGenics (MGNX): Millennium group discloses 3.7% beneficial stake in amended 13G - Stock Titan
MacroGenics stock gains after FDA priority review as revenue rises and cash runway extends - Ad-hoc-news.de
MacroGenics Inc (NASDAQ: MGNX) Share Price, MGNX Stock News, MGNX Share Price & Updates - Kalkine
[144] MACROGENICS INC SEC Filing - Stock Titan
Form 144 MACROGENICS For: 13 July By Investing.com - Investing.com Nigeria
MacroGenics (MGNX) Short Interest & Short Float | Updated Jul 2026 - MarketBeat
MGNX Q1 2026 Earnings: Narrower-Than-Expected Loss Amid Continued Pipeline DevelopmentOperating Margin Analysis - dars.gov.et
MacroGenics, Inc. 8-K SEC Filing July 2026: Company Details, Stock Info, and Key Regulatory Disclosures - Minichart
MacroGenics (MGNX) Slides Further as Stock Hovers Near Key Support LevelsTime Weighted Price - DonanımHaber
MacroGenics announces upcoming board change with director resignation - TipRanks
Karen Ferrante to Resign from MacroGenics' Board Effective Sept 1, 2026 - TradingView
Board member Karen Ferrante to leave MacroGenics (MGNX) board in September 2026 - Stock Titan
Macrogenics, Inc. Announces Resignation of Karen Ferrante from Director Role, Effective September 1, 2026 - marketscreener.com
MacroGenics Inc highlights its oncology pipeline as investors track future catalysts - Ad-hoc-news.de
MacroGenics Sells GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million - Minichart
MacroGenics Completes Asset Sale, Shifts to R&D Focus - TipRanks
MacroGenics (NASDAQ: MGNX) nets $110.7M and gain in CDMO sale - Stock Titan
Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Mfg. Ops - Contract Pharma
Bora Pharmaceuticals completes $122.5M buy of MacroGenics manufacturing operations - megaproject.com
M55 Forecast — Price Target — Prediction for 2027 - TradingView
MacroGenics (MGNX) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing OperationsBrand Spur - Brand Spur
MacroGenics completes sale of manufacturing operations to Bora By Investing.com - Investing.com Australia
MacroGenics completes sale of manufacturing operations to Bora - Investing.com
MacroGenics sells its drug-making operations to Bora for $122.5M - Stock Titan
Bora Pharmaceuticals Completes Acquisition Of Macrogenics' Rockville Manufacturing Operations - Menafn
Macrogenics | 4: Statement of changes in beneficial ownership of securities-Director O'Brien Federica F. - Moomoo
MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2500 Growth Benchmark - marketscreener.com
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2000 Value Benchmark - marketscreener.com
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2000 Growth Benchmark - marketscreener.com
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 3000E Index - marketscreener.com
Enterprise value to revenue forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 3000E Value Benchmark - marketscreener.com
Price to earnings forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView
Enterprise value to revenue forward of MacroGenics, Inc. – BOATS:MGNX - TradingView
Enterprise value to EBITDA forward of MacroGenics, Inc. – BOATS:MGNX - TradingView
MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Enterprise value to EBIT forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView
Enterprise value to EBIT forward of MacroGenics, Inc. – BOATS:MGNX - TradingView
Price to sales forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView
Price to book forward of MacroGenics, Inc. – BOATS:MGNX - TradingView
MGNX Forecast — Price Target — Prediction for 2027 - TradingView
MacroGenics, Inc. Actuals & Estimates (NASDAQ:MGNX) - TradingView
A1W6ND Forecast — Price Target — Prediction for 2027 - TradingView
MacroGenics Inc (MGNX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MacroGenics: 'Hold' Potential Best-In-Class B7-H3 ADC And TZIELD Payment (NASDAQ:MGNX) - Seeking Alpha
1.97%
0.83%
大文字化:
|
ボリューム (24 時間):